Journal Information
Vol. 37. Num. 10.October 2018
Pages 799-872
Share
Share
Download PDF
More article options
Vol. 37. Num. 10.October 2018
Pages 799-872
Erratum
DOI: 10.1016/j.repce.2018.10.003
Open Access
Errata to “Heart failure in numbers: Estimates for the 21st century in Portugal”
Errata a «Insuficiência Cardíaca em números: estimativas para o século XXI em Portugal»
Visits
47
Cândida Fonsecaa,c,
Corresponding author
mcandidafonseca@gmail.com

Corresponding author.
, Daniel Brásb, Inês Araújoa,c, Fátima Ceiac
a Unidade de Insuficiência Cardíaca, Serviço de Medicina III e Hospital Dia, Hospital São Francisco Xavier - Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal
b Departamento Médico, Novartis Farma - Produtos Farmacêuticos SA, Lisboa, Portugal
c NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal
Related content
Rev Port Cardiol 2018;37:97-10410.1016/j.repce.2017.11.017
Cândida Fonseca, Daniel Brás, Inês Araújo, Fátima Ceia
This item has received
47
Visits

Under a Creative Commons license
Article information
Full Text
Download PDF
Statistics
Tables (1)
Table 1. Estimates of absolute numbers of different types of heart failure in the population of mainland Portugal aged over 25 years.
Full Text

In the article “Heart failure in numbers: Estimates for the 21st century in Portugal” Rev Port Cardiol. 2018; 37 (2): 97-104, please consider the following corrections:

  • 1)

    In the Results section, for the number of individuals affected by the syndrome, “According to the EPICA study, the most common form of HF is HF with preserved systolic function, followed by HF due to systolic dysfunction. It is estimated that 126 898 patients will be suffering from HF with preserved systolic function in 2018. There will be a much higher prevalence among women, 96 762 of whom will have this form of HF in that year. Systolic dysfunction will be more prevalent among men, 65 408, 65 441, 57 769 and 51 381 of whom are likely to be affected by this type of HF in 2018, 2035, 2060 and 2080, respectively”, should read “According to the EPICA study, the most common form of HF is HF with preserved systolic function, followed by HF due to systolic dysfunction. It is estimated that 159 717 patients will be suffering from HF with preserved systolic function in 2018. There will be a much higher prevalence among women, 119 976 of whom will have this form of HF in that year. Systolic dysfunction will be more prevalent among men, 71 769, 79 477, 74 721 and 67 814 of whom are likely to be affected by this type of HF in 2018, 2035, 2060 and 2080, respectively.”

  • 2)

    In the Results section, for the number of individuals according to NYHA classification, “The number of individuals with HF under the NYHA classification was also estimated (fig. II). Thus, it is expected that 122 781 discharged patients will have NYHA class II HF in 2035, compared to over 136 000 patients who will be classified as class III or IV (fig. II).” should read “The number of individuals with HF according to the New York Heart Association (NYHA) was also estimated. Thus, it is expected that 143 496 discharged patients will be in NYHA class II HF in 2035, compared to over 136 000 patients who will be classified as class III or IV (Figure 2).”

  • 3)

    In the Discussion section, for the number of individuals affected by the syndrome, “An analysis of the projections by HF subtype indicates that by 2018 there will be 126 898 individuals with HF with preserved systolic function, most of whom will be elderly and female, in agreement with the existing literature.12” should read “An analysis of the projections by HF subtype indicates that by 2018 there will be 159 717 individuals with HF with preserved systolic function, most of whom will be elderly and female, in agreement with the existing literature.12”

  • 4)

    Table 1 should be replaced as follows:

    Table 1.

    Estimates of absolute numbers of different types of heart failure in the population of mainland Portugal aged over 25 years.

    HF subtypeSystolic dysfunction  Preserved systolic function  Valve disease  Pericardial disease  Right HF 
    EPICA prevalences 1998-2000  M (%)  1.91  0.88  0.68  0.05  0.63 
      F (%)  0.75  2.42  0.70  0.03  0.28 
    2011 Census  70 486  36 138  27 053  1 876  27 270 
      34 967  110 293  31 967  1 451  12 588 
      MF  105 453  146 431  59 020  3 327  39 858 
    Central scenario201871 769  39 741  27 910  2 110  29 438 
    38 625  119 976  33 877  1 573  13 589 
    MF  110 394  159 717  61 787  3 683  43 027 
    203579 477  50 831  32 924  2 681  38 090 
    48 193  145 298  39 739  2 063  16 105 
    MF  127 670  196 129  72 663  4 744  54 195 
    206074 721  52 613  33 643  3 014  38 478 
    50 660  151 777  44 097  2 134  14 948 
    MF  125 381  204 390  77 740  5 148  53 426 
    208067 814  48 360  31 244  2 728  36 152 
    43 347  129 836  37 979  1 876  12 747 
    MF  111 161  178 196  69 223  4 604  48 899 

    Prevalences for individuals in the Portuguese population over 25 years of age, according to HF subtype and gender, are presented for the period 1998-2000 (EPICA study). Projections for the number of individuals in the Portuguese population over 25 years of age, according to HF subtype and gender, are shown for the years 2011, 2018, 2035, 2060 and 2080. The prevalences of multifactorial and unknown classification HF subtypes are not shown. F: female; HF: heart failure; M: male; MF: sum of male and female.

Please cite this article as: Fonseca C, Brás D, Araújo I, Ceia F. Errata a “Insuficiência Cardíaca em números: estimativas para o século XXI em Portugal” . https://doi.org/10.1016/j.repce.2017.11.017.

Copyright © 2017. Sociedade Portuguesa de Cardiologia
Idiomas
Revista Portuguesa de Cardiologia (English edition)

Subscribe to our Newsletter

Article options
Tools
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos